We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breath Test Could Help Detect Blood Cancers

By LabMedica International staff writers
Posted on 24 Jul 2025

Blood cancers affect thousands of people annually, with around 40,000 new diagnoses and 16,000 deaths each year in the UK alone. More...

Diagnosing these cancers can be especially difficult in the early stages, as symptoms like fatigue and weight loss are vague and nonspecific. Current diagnostic methods rely on specialized tests such as imaging scans or biopsies, which are often costly, time-consuming, and not readily available in many regions. This lack of accessible and rapid testing limits early detection, which is crucial for successful treatment outcomes. Researchers have now identified certain molecules exhaled in the breath that could indicate the presence of blood cancers, opening the door to a non-invasive, low-cost, and rapid testing alternative.

Researchers from Queen Mary University of London (London, UK) conducted a study using a breathalyser technology called Breath Biopsy, developed by Owlstone Medical (Cambridge, UK). In the trial, the team collected exhaled breath samples from 46 people with blood cancer and 28 healthy individuals. The breath samples were analyzed using mass spectrometry to identify thousands of molecular fragments and establish chemical fingerprints. The study focused particularly on high-grade lymphoma, an aggressive form of blood cancer, and found significantly elevated levels of certain molecules in patients' breath. These molecules are associated with oxidative stress, a process linked to cell damage and cancer development. The goal was to determine whether blood cancer cells release molecules that transfer into the breath, offering a novel detection method.

Published in HemaSphere, the study showed for the first time that breath analysis could help detect blood cancers. The simplicity, portability, and affordability of breathalyser devices offer significant advantages, especially in low-resource settings that lack access to specialized diagnostic infrastructure. These devices could help monitor treatment progress and reduce dependency on expensive scans. Further research will focus on understanding how these airborne molecules are produced and determining which subtypes of lymphoma are most detectable through this method. The team also aims to shorten breath collection times from 10 minutes to just a few seconds and improve the sensitivity and specificity of future breath tests.

“In future, rather than sending patients away for costly scans and waiting for test results, doctors may be able to conduct a quick breath test in their clinic room and potentially have the results within a few seconds,” said Dr. John Riches, lead researcher of the study.

Related Links;
Queen Mary University of London
Owlstone Medical


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Sample Transportation System
Tempus1800 Necto
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.